Terms: = Lung cancer AND CNOT3, KIAA0691, 4849, ENSG00000088038, O75175, NOT3H, NOT3, LENG2
8 results:
1. Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
Huntley C; Torr B; Sud A; Rowlands CF; Way R; Snape K; Hanson H; Swanton C; Broggio J; Lucassen A; McCartney M; Houlston RS; Hingorani AD; Jones ME; Turnbull C
Lancet Oncol; 2023 Jun; 24(6):658-668. PubMed ID: 37178708
[TBL] [Abstract] [Full Text] [Related]
2. cnot3 interacts with the Aurora B and MAPK/ERK kinases to promote survival of differentiating mesendodermal progenitor cells.
Sarkar M; Martufi M; Roman-Trufero M; Wang YF; Whilding C; Dormann D; Sabbattini P; Dillon N
Mol Biol Cell; 2021 Dec; 32(22):ar40. PubMed ID: 34613789
[TBL] [Abstract] [Full Text] [Related]
3. cnot3 contributes to cisplatin resistance in lung cancer through inhibiting RIPK3 expression.
Jing L; Zhai ME; Cui J; Fan XY; Cheng YY; Jiang JL; Chen ZN
Apoptosis; 2019 Aug; 24(7-8):673-685. PubMed ID: 31177396
[TBL] [Abstract] [Full Text] [Related]
4. cnot3 targets negative cell cycle regulators in non-small cell lung cancer development.
Shirai YT; Mizutani A; Nishijima S; Horie M; Kikuguchi C; Elisseeva O; Yamamoto T
Oncogene; 2019 Apr; 38(14):2580-2594. PubMed ID: 30531840
[TBL] [Abstract] [Full Text] [Related]
5. A new scoring system for predicting survival in patients with non-small cell lung cancer.
Schild SE; Tan AD; Wampfler JA; Ross HJ; Yang P; Sloan JA
Cancer Med; 2015 Sep; 4(9):1334-43. PubMed ID: 26108458
[TBL] [Abstract] [Full Text] [Related]
6. Opportunities for translational epidemiology: the important role of observational studies to advance precision oncology.
Marrone M; Schilsky RL; Liu G; Khoury MJ; Freedman AN
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):484-9. PubMed ID: 25750251
[TBL] [Abstract] [Full Text] [Related]
7. Mortality patterns among industrial workers exposed to chloroprene and other substances. I. General mortality patterns.
Marsh GM; Youk AO; Buchanich JM; Cunningham M; Esmen NA; Hall TA; Phillips ML
Chem Biol Interact; 2007 Mar; 166(1-3):285-300. PubMed ID: 16999943
[TBL] [Abstract] [Full Text] [Related]
8. Patients' immune response to breast and lung carcinoma-associated Thomsen-Friedenreich (T) specificity.
Springer GF; Murthy SM; Desai PR; Fry WA; Tegtmeyer H; Scanlon EF
Klin Wochenschr; 1982 Feb; 60(3):121-31. PubMed ID: 6176752
[TBL] [Abstract] [Full Text] [Related]
